New life-saving heart drug , BRILINTA, approved

Tuesday, 23 August 2011, 4:15 pm | FWC

Brilinta (ticagrelor), a new and important treatment advance for patients with acute coronary syndrome, has been approved by Medsafe for use in New Zealand. BRILINTA is an oral antiplatelet treatment for acute coronary syndrome (ACS) in a new chemical ... More >>